Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Davis, S; Rafia, R; Carroll, C; Hamilton, J; Essat, M

Davis, S (reprint author), Univ Sheffield, ScHARR, 30 Regent St, Sheffield S1 4DA, S Yorkshire, England.

PHARMACOECONOMICS, 2019; 37 (6): 763

Abstract

The National Institute for Health and Care Excellence (NICE) published guidance on the use of pirfenidone (Esbriet((R)), Roche) for the treatment of m......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索